Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COTSOM: TACE and Sorafenib in Metastatic HCC
NCT02311205Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02311205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311205.